The RNA-binding protein DND1 acts Sequentially as a negative regulator of pluripotency and a positive regulator of epigenetic modifiers required for germ cell reprogramming.

dc.contributor.author

Ruthig, Victor A

dc.contributor.author

Friedersdorf, Matthew B

dc.contributor.author

Garness, Jason A

dc.contributor.author

Munger, Steve C

dc.contributor.author

Bunce, Corey

dc.contributor.author

Keene, Jack D

dc.contributor.author

Capel, Blanche

dc.date.accessioned

2019-08-01T15:03:01Z

dc.date.available

2019-08-01T15:03:01Z

dc.date.issued

2019-06-28

dc.date.updated

2019-08-01T15:03:00Z

dc.description.abstract

The adult spermatogonial stem cell population arises from pluripotent primordial germ cells (PGCs) that enter the fetal testis around embryonic day (E)10.5. PGCs undergo rapid mitotic proliferation, then enter prolonged cell cycle arrest (G1/G0) during which they transition to pro-spermatogonia. In mice homozygous for the Ter mutation in the RNA-binding protein Dnd1 (Dnd1 Ter/Ter ), many male germ cells (MGCs) fail to enter G1/G0, and form teratomas, tumors containing many embryonic cell types. To investigate the origin of these tumors, we sequenced the MGC transcriptome in Dnd1 Ter/Ter mutants at E12.5, E13.5, and E14.5, just prior to teratoma formation, and correlated this information with DO-RIP-Seq identified DND1 direct targets. Consistent with previous results, we found DND1 controls down-regulation of many genes associated with pluripotency and active cell cycle, including mTor, Hippo and Bmp/Nodal signaling pathway elements. However, DND1 targets also include genes associated with male differentiation including a large group of chromatin regulators activated in wild type but not mutant MGCs during the E13.5 and E14.5 transition. Results suggest multiple DND1 functions, and link DND1 to initiation of epigenetic modifications in MGCs.

dc.identifier

dev.175950

dc.identifier.issn

0950-1991

dc.identifier.issn

1477-9129

dc.identifier.uri

https://hdl.handle.net/10161/19142

dc.language

eng

dc.publisher

The Company of Biologists

dc.relation.ispartof

Development (Cambridge, England)

dc.relation.isversionof

10.1242/dev.175950

dc.subject

DO-RIP-Seq

dc.subject

Dnd1

dc.subject

Germ Cells

dc.subject

RNAseq

dc.subject

Teratoma

dc.title

The RNA-binding protein DND1 acts Sequentially as a negative regulator of pluripotency and a positive regulator of epigenetic modifiers required for germ cell reprogramming.

dc.type

Journal article

duke.contributor.orcid

Capel, Blanche|0000-0002-6587-0969

pubs.begin-page

dev.175950

pubs.end-page

dev.175950

pubs.organisational-group

School of Medicine

pubs.organisational-group

Duke

pubs.organisational-group

Duke Cancer Institute

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Molecular Genetics and Microbiology

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Medicine, Rheumatology and Immunology

pubs.organisational-group

Medicine

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Cell Biology

pubs.publication-status

Published

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Ruthig-Keene-Capel RBP DND1neg pluripot and pos epitgenetic modif Dev19.pdf
Size:
9.74 MB
Format:
Adobe Portable Document Format
Description:
Published version